Pharmacotherapy of ectoparasitic infections

Drugs

Volumn 61, Issue 8, 2001, Pages 1067-1088

  Ross, Thomas Christian ^a   Alam, Murad ^b   Ross, Sabine ^a   Merk, Hans Friedrich ^a   Bickers, David R ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLETHRIN; ANTIPARASITIC AGENT; BALSAM PERU; BENZYL BENZOATE; CHLORPHENOTANE; CROTAMITON; FLUBENDAZOLE; FORMIC ACID; HEXACHLOROPHENE; INSECTICIDE; IVERMECTIN; LINDANE; MALATHION; MESULFEN; NITROFURAL; ORGANOCHLORINE DERIVATIVE; ORGANOPHOSPHATE INSECTICIDE; PERMETHRIN; SULFUR; TIABENDAZOLE; UNCLASSIFIED DRUG; VINEGAR;

ARTHRALGIA; CIMEX; DEATH; DRUG ABSORPTION; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; INFESTATION; LYMPHADENOPATHY; NEUROTOXICITY; PEDICULOSIS; PEDICULUS; REVIEW; SARCOPTES SCABIEI; SCABIES; TOPICAL TREATMENT;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANTI-INFECTIVE AGENTS; CHILD; DRUG RESISTANCE; ECTOPARASITIC INFESTATIONS; HUMANS; INSECTICIDES; IVERMECTIN; PERMETHRIN;

EID: 0034940429     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161080-00004     Document Type: Review

References (247)

1. Scabies in AIDS
2. A risk-benefit assessment of agents used in the treatment of scabies
3. Resistance to antiscabietic drugs
4. Resistance to antiscabietic drugs
5. A comparative trial of three treatment schedules for the eradication of scabies
6. An outbreak of lindane-resistant scabies treated successfully with permethrin 5% cream
7. Lindane resistant scabies
8. Scabies resistant to lindane 1% lotion and crotaminon 10% cream
9. Gamma benzene hexachloride resistant scabies
10. Nosocomial outbreak of scabies clinically resistant to lindane
11. Community control of scabies: A model based on use of permethrin cream
12. Ivermectin als orale einmalbehandlung der skabies
13. Besonderheiten der skabiestherapie. Schwangerschaft, ivermectin, resistenzprobleme
14. The gamma isomer of hexachlorcyclohexane
15. The gamma isomer of hexachlorcyclohexane in the treatment of scabies
16. Die behandlung der scabies und der pediculosen mit gamma-hexachlorcyclohexan
17. Hexachlorcyclohexan und verwandte stoffe
18. Treatment of ectoparasitic infections: Review of the English-language literature, 1982-1993
19. Percutaneous penetration of some pesticides and herbicides in man
20. Quantitative distribution if locally applied lindane in human skin and subcutaneous fat in vitro
21. Dermal absorption of the insecticide lindane in rats and rhesus monkeys: Effect of anatomical sites
22. Comparative percutaneous absorption of lindane and permethrin
23. Occupational exposure to hexachlorcyclohexane: I. Body burden of HCH-isomers
24. Occupational exposure to hexachlorcyclohexane: II. Neurophysiological findings and neuromuscular function in chronically exposed workers
25. The German Environmental Survey 1990/1992 (GerES II): Reference concentrations of selected environmental pollutants in blood, urine, hair, house dust, drinking water and indoor air
26. Management of acute childhood poisonings caused by selected insecticides and herbicides
27. A review of organophosphate poisoning
28. Effects of lindane treatment on drug metabolizing enzymes and liver weight of CFI mice in which is evoked hepatomas and in non-susceptible rodents
29. Percutaneous absorption, dermatopharmacokinetics and related bio-transformation studies on carbaryl, lindane, malathion, and parathion in isolated perfused porcine skin
30. Elimination of beta-bexachlorocyclohexane in occupationally exposed persons
31. Comparative study in the acute toxicities of alpha, beta, gamma and delta isomers of hexachlorcyclohexane to freshwater fishes
32. Lindane poisonings
33. Scabies in children
34. A contribution to the question of the possible hepatocarcinogenic effects of lindane
35. The potency of gamma-1,2,3,4,5,6-hexachlorcyclo-hexane (lindane)
36. Lindane
37. Gamma benzene hexachloride toxicity: A review
38. The problem of lindane
39. Treatment of scabies and pediculosis with lindane preparations: An evaluation
40. Lindane: A prudent approach
41. Effects of insecticides on GABA-induced chloride influx into rat brain microsacs
42. Factors responsible for increased excitability of dentate gyrus granule cells during exposure to lindane
43. CNS biochemical and pharmacological effects of the isomers of hexachlorcyclohexane (lindane) in the mouse
44. BHC isomers and related compounds. VIII. Inhibitory effects of BHC and nerve conduction
45. The action of lindane in accelerating the spontaneous release of neurotransmitter at the frog neuromuscular junction
46. Inhibition of synaptic ATPase by rheptachlorepoxide in rat brain
47. Effects of pesticides on frog skeletal muscle sarcolemmam enzymes
48. Effects of lindane on calcium fluxes in synaptosomes
49. Behavioral and monoaminergic changes after lindane exposure in developing rats
50. Serious poisoning by hexachlorohexane
51. Benzene hexachloride
52. Carcinogenicity study of lindane in the mouse
53. Teratogenicity studies on pesticide formulations of dimethoate diuron and lindane in rats
54. Effect of lindane on pregnancy in the rabbit and rat
55. Comparative teratological studies on TCDD, endrin and lindane in C57BL/6J and DBA/2J mice
56. Reproductive toxicity and toxicokinetics of lindane in the male offspring of rats exposed during lactation
57. Serum testosterone and sexual behavior in rats after prenatal exposure to lindane
58. Mutagenicity testing of commercial insecticides administered per os
59. Assessment of genotoxic effects by lindane
60. Pesticides and cancer
61. The chronic toxicities of technical benzene hexachloride and its alpha, beta and gamma isomers
62. Contributions to ecology II: Hepatoma development in mice after administration of HCH isomers in high dosages
63. Induction of hepatoma in mice by benzene hexachloride
64. The toxicity of dieldrin II: Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC, and gamma-BHC
65. Carcinogenicity of hexachlorcyclohexane (beta-HCH) in pure inbred Swiss mice
66. Increased responsiveness of lean pseudoagouti Avy/a female mice to lindane enhancement of lung and liver tumorgenesis
67. Dose-response studies on the effect of á-, â-, and ã-hexachlorocyclohexane on putative preneoplastic foci, monooxigenases, and growth in rat liver
68. Tumorigenic responses in mice: Potentiation by a dominant mutation
69. Multiple levels of response in carcinogenicity bioassays: Regulational variation among viable yellow (Avy//-)mice
70. Detection of genotoxic effects in human gastric mucosa and nasal mucosa cells isolated from biopsy samples
71. Effects of organochlorine pesticides on DNA synthesis of cultured oviductal and uterine cells and on estrogen receptor of uterine tissue from heifers
72. Demonstration of initiation potential of carcinogens by induction of preneoplastic glutathione S-transferase P-form-positive liver cell foci: Possible in vivo assay system for environmental carcinogens
73. Genotoxic effects of alpha-hexachlorocyclohexane in primary cultures of rodent and human hepatocytes
74. Effects of lindane on membrane fluidity: Intramolecular excimerization of pyrene derivative and polarization of diphenylhexatriene
75. Liver lipid peroxidation-related parameters after short-term administration of hexachlorcyclohexane isomers to rats
76. Influence of lindane and paraquat on oxidative stress-related parameters of erythrocytes in vitro
77. Comparison of hexachlorocyclo-hexanes-induced stress in the testis of immature and adult rats
78. Occupational exposure to hexachlorcyclohexane: III. Health conditions of chronically exposed workers
79. Serum hexachlorcyclohexane residues in workers engaged at a HCH manufacturing plant
80. Occupational exposure to lindane: Clinical laboratory findings
81. Plasma gamma-hexachlorcyclohexane concentrations in forestry workers exposed to lindane
82. Chronische lebererkrankungen nach beruflicher einwirkung von dichlordiphenyltrichlorethan und hexachlorcyclohexan (HCH)
83. Gamma benzene hexachloride (Kwell-) induced aplastic anaemia
84. Lindane haematotoxicity conformed by in vitro tests on human and rat progenitors
85. Hematological effects of hexachlorcyclohexane (HCH) in mice: Results and possibilities
86. Human exposure to lindane: Comparison of an exposed and an unexposed population
87. Human exposure to lindane: Clinical hematological and biochemical effects
88. Efficacy of ivermectin against Dirofilaria immitis larvae in dogs 31, 60 and 90 days after infection
89. Aplastic anaemia and occupational pesticide exposure: A case control study
90. Anaemia associated with exposure to lindane
91. Scabies, lice, and fungal infections
92. Operational criteria for adverse drug reactions in evaluating suspect toxicity of a popular scabicide
93. Adverse drug reactions in dermatologic therapy
94. The percutaneous absorption and skin distribution of lindane in man: I. In vivo studies
95. The percutaneous absorption and skin distribution of lindane in man: II. In vitro studies
96. Scabies in infants and small children
97. A test series for pesticide dermatitis
98. Irritation and sensitization potentialof pesticides
99. Sogenannte postscabiöse dermatitis
100. Absorption of gamma benzene hexachloride following application of Kwell shampoo
101. Absorption of lindane (gamma benzene hexachloride) in infants and children
102. Percutaneous absorption of lindane in healthy volunteers and scabies patients
103. Transcutaneous poisoning during treatment
104. Transcutaneous gamma benzene hexachloride absorption and toxicity in infants and children
105. Demonstration of percutaneous absorption of a lipophilic pesticide and its possible storage in the human body
106. Short and long-term risks of topical drugs
107. Scabies therapy-1993
108. Scabies treatment: Current considerations
109. Topical application of lindane cream (Kwell) and antipyrine metabolism
110. Lindane reaction in nonbullous congenital ichthiosis form of erythroderma
111. Therapiebedingte lindankonzentration in der muttermilch
112. Insecticide residues in pheasant after being on wheat seed treated with heptachlor and 14C-lindane
113. Chlorierte kohlenwasserstoffe im blut des menschen unter bedingungen der nahrungskarenz
114. Treatment of scabies with permethrin versus lindane and benzyl benzoate
115. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies
116. Permethrin 5% dermal cream: A new treatment for scabies
117. Comparison of crotaminon 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children
118. Permethrin versus crotaminon and lindane in the treatment of scabies
119. Comparison of ivermectin and benzylbenzoate for treatment of scabies
120. Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies
121. Crotamiton - Eine wirksame und sichere substanz für die therapie der scabies. Ergebnisse einer kontrollierten klinischen prüfung
122. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies
123. 1% permethrin cream rinse vs 1% lindane shampoo in treating pediculosis capitis
124. Comparative study of permethrin 1% creme rinse and lindane shampoo for the treatment of head lice
125. Treatment of pediculosis pubis. Clinical comparison of efficacy and tolerance of 1% lindane shampoo vs 1% permethrin creme rinse
126. Nationwide comparative trial of pyrethrins and lindane for pediculosis in children: Experience in northeastern United States
127. Pyrethrins combined with piperonyl butoxide (RID) vs 1% permethrin (NIX) in the treatment of head lice
128. Eradication of head lice with a single treatment
129. Safety of permethrin vs lindane for the treatment of scabies
130. Therapy of scabies: Nursing homes, hospitals and the homeless
131. Postmarketing surveillance study of permethrin creme rinse
132. Scabies
133. Chronic toxicity and carcinogenic evaluation of permethrin in rats and mice
134. Degradation, metabolism and toxicity of synthetic pyrethroids
135. Mass balance and dose accountability in percutaneous absorption studies: Development of a nonocclusive application system
136. A photostable pyrethroid
137. Radiosynthesis and metabolism in rats of 1R isomers of the insecticide permethrin
138. Permethrin metabolism in rats
139. Method for determination of first-pass metabolism in human skin
140. Percutaneous absorption of cis- and trans-permethrin in rhesus monkeys and rats: Anatomic sites and interspecies variation
141. Treatment of scabies: Preliminary report
142. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies
143. Evidence for double resistance to permethrin and malathion in head lice
144. Pyrethroid resistance mechanisms in the head louse Pediculus capitis from Israel: Implications for control
145. Differential permethrin susceptibility of head lice sampled in the United States and Borneo
146. Images in clinical medicine: Norwegian scabies in a patient with AIDS
147. Norwegian scabies in a patient with AIDS
148. Neonatal scabies treated with permethrin 5% cream
149. Efficacy and transdermal absorption of permethrin in scabies patients
150. Über ein neues antiscabiosum
151. Pharmacokinetics of crotaminon following topical application to healthy volunteers
152. Clinical experience with crotaminon cream and lotion in treatment of infants with scabies
153. Alte und neue dermatika: Verwendung von antimikrobika und antiparasitika in mitteleuropäischen kliniken
154. Crotaminon cream and lotion in the treatment of infants and young children with scabies
155. A single application of crotaminon in the treatment of patients with pediculosis capitis
156. Advances in pediculosis, scabies and other mite infestations
157. The treatment of scabies with ivermectin
158. Irritative contact dermatitis to scabicides as a sort of postscabies dermatitis
159. Sulfur revisited
160. Sulfur revisited
161. Toxicological investigations of compounds proposed for use as insect repellents
162. Monographs on fragrance raw materials
163. Penetration of fragrance compounds through human epidermis
164. Poisoning of cats with benzyl benzoate
165. Benzoyl peroxide
166. Difficulties in the treatment of scabies in infants
167. Systematic review of clinical efficacy of topical treatments for head lice
168. Use of hexachlorophene in the treatment and prevention of scabies
169. Clinical study of the antiparasital activity of BPH 3004 (Mitigal Spray) in scabies and pubic pediculosis
170. Neonatal scabies
171. Insect bites and parasitic infestations
172. Clinical evaluation of an after-pediculocide nit removal system
173. Comparison of ivermectin and dimethylcarbamazine in the treatment of onchocerciasis
174. Use of ivermectin in humans
175. Onchocerciasis in New York City: The Moa-Manhattan connection
176. Mass chemoprophylaxis of lymphatic filariasis with a single dose of ivermectin in a Polynesian community with a high Wucheria bancrofti infection rate
177. Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis
178. The use of ivermectin for scabies
179. Orale therapie einer lindanresistenten skabies crustosa mit ivermectin
180. Ivermectin
181. Orale behandlung der scabies mit ivermectin
182. Clinical pharmacology of ivermectin
183. The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution
184. Deaths associated with ivemectin treatment of scabies
185. Deaths after ivermectin treatment
186. We can get rid of scabies: New treatment available soon
187. Efficacy of ivermectin in the treatment of an epidemic of sarcoptic scabies
188. Ivermectin for crusted (Norwegian) scabies
189. Treatment of HIV-related scabies with emphasis on the efficacy of ivermectin
190. We can get rid of scabies: New treatment available soon
191. Critical review of scabies treatments
192. Sexually transmitted diseases: Treatment guidelines
193. Drags for sexually transmitted diseases
194. Interventions for treating headlice
195. Resistance and the control of lice on humans and production animals
196. Water balance and nutrient procurement of Sarcoptes scabiei var canis (Acari: Sarcoptidae)
197. Pharmacist intervention to control lice resistance
198. Comparing antiscabies treatments
199. Diagnosis and treatment of childhood scabies and pediculosis
200. Scabies
201. Treatment of endemic scabies with allethrin, permethrin and ivermectin. Evaluation of a treatment strategy
202. A systematic review of the treatment of scabies
203. Comparing topical scabietic treatments will soon become extinct
204. Outbreak of scabies in Norwegian nursing homes and home care patients: Control and prevention
205. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis